Terminated NCT05211947
This study was terminated in the United States, in Australia, in France, .... It focuses on schizophrenia.
Multiple locations, including Anaheim Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 51 Years
Countries United States, Australia, France, ...
Sponsor Boehringer Ingelheim
Condition Schizophrenia Completed NCT04521478
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Birmingham Depression Drug From 18 Years to 65 Years
Countries United States, Australia, France, ...
Sponsor Boehringer Ingelheim
Condition Depression Completed NCT00088634
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Birmingham Schizophrenia Drug From 18 Years to 64 Years
Countries United States
Sponsor Sumitomo Pharma America, Inc.
Condition Schizophrenia Completed NCT00827918
This study is completed. It focuses on schizophrenia.
Location not clearly listed Schizophrenia Drug From 18 Years to 55 Years
Countries
Sponsor Merck Sharp & Dohme LLC
Condition Schizophrenia Completed NCT00475735
This study exists to compare options and see whether this type of care offers something meaningfully different. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.
Location not clearly listed ADHD Drug From 18 Years to 55 Years
Countries
Sponsor Merck Sharp & Dohme LLC
Condition ADHD Completed NCT00088621
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Birmingham Schizophrenia Drug From 18 Years to 64 Years
Countries United States
Sponsor Sumitomo Pharma America, Inc.
Condition Schizophrenia Suspended NCT06628622
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Los Alamitos Addiction Drug From 18 Years to 65 Years
Countries United States
Sponsor Boehringer Ingelheim
Condition Addiction Completed NCT05103657
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Little Rock PTSD Drug From 18 Years to 65 Years
Countries United States, Croatia, Finland, ...
Sponsor Boehringer Ingelheim
Condition PTSD Completed NCT04532619
This summary needs review. Please check the official study record and contact the research team for details.
In Eugene Addiction Behavioral Over 18 Years
Countries United States
Sponsor University of Oregon
Condition Addiction Completed NCT00134927
This summary needs review. Please check the official study record and contact the research team for details.
In La Jolla Addiction Other Over 18 Years
Countries United States
Sponsor National Institute on Drug Abuse (NIDA)
Condition Addiction Completed NCT03403790
This study exists to understand whether questionnaires and follow-up reports is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to questionnaires and follow-up reports in practice and what may need to be adjusted.
Multiple locations, including Aichi Bipolarity, Depression Drug
Countries Japan
Sponsor Astellas Pharma Inc
Condition Bipolarity, Depression Completed NCT03809325
This study is completed in France, in the United Kingdom, in Belgium, .... It focuses on Schizophrenia.
Multiple locations, including Brussels Schizophrenia Drug Over 18 Years
Countries France, United Kingdom, Belgium, ...
Sponsor Janssen-Cilag International NV
Condition Schizophrenia